Sandbox Reserved 1449: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 15: Line 15:
== Structural highlights ==
== Structural highlights ==


== dlfkaslkdfj ==


This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
Line 23: Line 22:
<references/>
<references/>


1. Pan, G. W. (2013, October 01). Mu Opioids and Their Receptors: Evolution of a Concept. Retrieved April 11, 2018, from http://pharmrev.aspetjournals.org/content/65/4/1257
3. Pan, G. W. (2013, October 01). Mu Opioids and Their Receptors: Evolution of a Concept. Retrieved April 11, 2018, from http://pharmrev.aspetjournals.org/content/65/4/1257


2. Kaserer, T., Lantero, A., Schmidhammer, H., Spetea, M., & Schuster, D. (2016, February 18). μ Opioid receptor: Novel antagonists and structural modeling. Retrieved April 11, 2018, from https://www.nature.com/articles/srep21548
4. Kaserer, T., Lantero, A., Schmidhammer, H., Spetea, M., & Schuster, D. (2016, February 18). μ Opioid receptor: Novel antagonists and structural modeling. Retrieved April 11, 2018, from https://www.nature.com/articles/srep21548